-
The Evolution of Pharma Depends on Data Integration and Application
The potential applications for this vast quantity and variety of data are nearly endless.
PAP-Q4-18-NI-001 -
The Coming of Age of Amorphous Solid Dispersions
Numerous drugs formulated as amorphous solid dispersions have been successfully commercialized.
PAP-Q4-18-CL-004 -
From Proof of Concept to Commercialization
Brammer’s vision is to be the leading CDMO for viral vector supply to cell and gene therapy innovators.
PAP-Q4-18-CL-003 -
Knowledge and Experience Equal Successful Technology Transfer
Technology transfer should result in the transfer of product and process knowledge into a new phase of the life cycle.
PAP-Q4-18-CL-008 -
A Turnkey Solution: Sourcing Equipment and Empowering Operators
We offer a turnkey solution by sourcing equipment that meets production line requirements.
PAP-Q4-18-CL-007 -
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
An oligo drug manufacturing facility incorporates aspects of small-molecule and biologic drug facilities.
PAP-Q4-18-CL-002 -
Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate
The FDA issued new guidances regarding enforcement of the DSCSA's track and trace mandate.
PAP-Q4-18-NI-011 -
Big Data in Drug Development and Discovery
Companies that apply the data will have a competitive advantage in drug discovery and development.
PAP-Q4-18-NI-006 -
Big Data in Drug Manufacturing
To achieve cohesive data integration in drug manufacturing, systems must be aligned.
PAP-Q4-18-NI-005 -
Big Data in Drug Packaging and Distribution
The emphasis on serialization is a tangible move toward making post-market data mining more robust.
PAP-Q4-18-NI-004 -
Preparing Clinical Trial Logistics for a No-Deal Brexit
Pharmaceutical companies should prepare for Brexit by mitigating their supply chain risks.
PAP-Q4-18-CL-006 -
Drug Repositioning: Facilitating Drug Repositioning with Artificial Intelligence
Computer-based approaches are essential to enable systematic drug repositioning efforts.
PAP-Q4-18-NI-009 -
The Value of Complementary Specialized Capabilities
Continued investment in innovations that address the needs of current and next-generation therapies is essential.
PAP-Q4-18-CL-001 -
Risk Minimization with an Integrated Global Network
Collaborating with an embedded organization with an integrated, global network can facilitate access to growing markets.
PAP-Q4-18-CL-005 -
Preparative Chromatography
Servier’s InnoPreP™ technology offering appeals to mid-size pharmas who need to quickly move their project into clinical studies .
PAP-Q4-18-NI-002 -
New Drug News: Regulatory Approval Brings siRNA into the Rare Disease Toolbox
siRNA joins the other nucleic acid–based drugs entering the marketplace for the treatment of rare diseases.
PAP-Q4-18-NI-010 -
Foreign Investment: Chinese Capital Backs U.S. Biotech
Given the amount of Chinese capital and the growing interest in the segment, the market feels unlimited.
PAP-Q4-18-NI-008 -
Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?
Industry leaders discuss recent technological innovations.
PAP-Q4-18-NI-007 -
Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?
Industry leaders discuss forthcoming technological innovations.
PAP-Q4-18-NI-003
-
The Coming of Age of Amorphous Solid Dispersions
Márcio Temtem, Director for Drug Product Development at Hovione, discusses drug formulation using amorphous solid dispersions.
-
How to Tell If You’re Using a Quality Hard Capsule
Bahi Mahesan, Regulatory Affairs and Quality Manager for CapsCanada, explains the benefits of using a high-quality supplier for hard-shell capsules.
-
What is the Most Significant Recent Advancement in Downstream Bioprocessing Technology? Why is it so Important?
Experts weigh in on our Roundtable question.
-
Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate
In late September, the U.S. Food and Drug Administration (FDA) issued a pair of draft guidances related to the implementation of product identifiers as mandated by the Drug Supply Chain Security Act (DSCSA).
-
How is the Need to Provide Local Drug-Product Supply in Multiple Regions Around the World Impacting Pharmaceutical Manufacturing Facility and Equipment Design?
Experts from across the industry lend their thoughts to the Roundtable.
-
Drug Repositioning: Facilitating Drug Repositioning with Artificial Intelligence
Repositioning existing drug substances for the treatment of different indications can significantly reduce the cost and time required for the development of new medicines.
-
Proposed U.S. Rules Would Eliminate Rebate Deals Between Drug Makers and Pharmacy Benefit Managers
New safe harbor provision will allow drug makers to give discounts directly to consumers.
-
Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.
Auris Health's robotic platform expands Johnson & Johnson's digital surgery portfolio.
-
Statement from FDA Commissioner Scott Gottlieb, M.D. on New Programs to Promote the Adoption of Innovations in Drug Manufacturing
Ensuring the safety of our nation's drug supply is a cornerstone of our consumer protection mission.
-
Alexion Acquires Minority Stake in Caelum Biosciences
Alexion will acquire the rest of the company if phase II data for anti-amyloid antibody CAEL-101 are positive.
-
Creating Comprehensive Solutions through Laboratory Testing
Xin Zhang, Ph.D., Vice President & Global Head of DMPK, Bioanalysis & Abgent, Eugene Gong, Ph.D., Vice President, Head of Technology Operations & Analytical & Regulatory CMC and Ed Amat, Vice President of International Sales & Marketing for WuXi AppTec discuss the company’s Laboratory Testing Division.
-
Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile
Wes Wheeler, CEO of Marken explains how Direct-to-Patient (DTP) clinical trials are becoming an industry standard.
-
The Evolution of Pharma Depends on Data Integration and Application
The pharmaceutical industry must respond to increasing pressure to rapidly develop cost-effective, fairly priced medicines.
-
Leveraging Lyophilization Development Expertise for Clinical Manufacturing
By late 2018, AB BioTechnologies, Inc.will be providing cGMP manufacturing of Phase I-III clinical trial material and small-volume commercial products, says Jeff Schwegman, Founder & CEO.
-
Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility
Peter Boeddeker, Director of Quality Management at Baxter BioPharma Solutions describes the challenges and advantages of multi-product facilities.
-
Building a Biologics Business from the Ground Up
Achieving success requires the right strategy, explains Hannes Teissl, Vice President, Biologics at Polpharma Biologics.
-
U.S. FDA Approves Botox Competitor
Evolus has secured approval for Jeuveau.
-
BHB Therapeutics Launched to Develop Medicines to Prevent Age-Related Diseases
Company formed by Juvenescence and the Buck Institute for Research on Aging will develop drugs that induce a state of ketosis.
-
FDA Advisory Committee Recommends Approval of SPRAVATO™ (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression
The committees based their support on the safety and efficacy data from five Phase 3 studies in patients with treatment-resistant depression: three short-term studies; one maintenance of effect study; and one long-term safety study.
-
Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic
The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA.
Nice Insight Awareness/Perception Scorecard
Research. Compare. Contact. Find the Ideal Partner.
Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.
- Search by company type, region, market segment and services.
- Select up to 5 companies to compare.
- View CA & CP performance scores against industry benchmark ratings.
Latest
View All LatestResearchers May Have Found Method for Detecting Consciousness
Feb 14, 2019 2:36:28 PM PAO-M02-19-NI-012Trump Signs Executive Order Launching the American AI Initiative
Feb 14, 2019 2:32:22 PM PAO-M02-19-NI-012Proposed U.S. Rules Would Eliminate Rebate Deals Between Drug Makers and Pharmacy Benefit Managers
Feb 7, 2019 3:55:39 PM PAO-M02-19-NI-008BHB Therapeutics Launched to Develop Medicines to Prevent Age-Related Diseases
Feb 7, 2019 3:50:22 PM PAO-M02-19-NI-006EMA Committee Recommends Approval of Teva’s Anti-CGRP Treatment for Migraines
Feb 6, 2019 4:33:28 PM PAO-M02-19-NI-003
TOPICS
View All TopicsPRESS RELEASES
View All-
Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.
Feb 15, 2019 5:00:00 AM -
Abilita Bio and Amgen Enter Into a Multi-Target Collaboration
Feb 15, 2019 5:00:00 AM -
Discovery Life Sciences Launches Major European Expansion
Feb 15, 2019 5:00:00 AM
Nice Insight Industry Benchmark Reports 2017
Download Sample Report
